Institute for Advanced Reconstruction
Institute for Advanced Reconstruction Announces First-of-Its-Kind Prospective Study of GLP-1 Receptor Agonists for Lymphedema TreatmentLymphedema Expert Dr. Joseph Dayan Leads Study on Potential of Weight-Loss and Diabetes Drugs Like Ozempic…